Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Aptuit has announced that Dr. Maurizio Denaro has assumed responsibilities as General Manager of The Aptuit Center for Discovery & Development in Verona, Italy, effective July 15, 2013.
read more
Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business Development and Marketing, making him responsible for all of Aptuit's sales and marketing activities.
read more
Wednesday, December 04, 2013
Timothy C. Tyson, Chairman of Aptuit LLC, announced today the appointment of Jonathan Goldman, MD as Chief Executive Officer (CEO), completing the company’s senior management leadership team.
read more
Monday, November 28, 2016
Aptuit announced that Peter Gray has been appointed Chairman of Aptuit's Board of Managers.
Mr. Gray assumes the role of Chairman having previously served as Non-Executive Director since March 2015.
read more
Monday, February 11, 2013
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced the availability of GLP-qPCR Biodistribution Studies required as part of the preclinical development study package for application in First In Man (FIM) of Gene Therapy ...
read more
Wednesday, March 27, 2013
Aptuit announces that it offers fast screenings of synaptic activity on hippocampal slices for clients who are focused on the central nervous system (CNS) therapeutic area.
read more
Thursday, January 31, 2019
Aquestive Therapeutics has learned its licensee, Sunovion Pharmaceuticals, received a CRL from the FDA in response to the NDA for apomorphine sublingual film (APL-130277).
read more
Wednesday, December 15, 2021
Aragen Life Sciences, a global research, development, and manufacturing solutions provider (CRO/CDMO), has signed a definitive agreement to acquire Pune-based Intox Pvt. Ltd. This acquisition will expand Aragen’s end-to-end integrated discovery and ...
read more
Aragen announced two senior level appointments. Dr. Manjunath Ramarao has been appointed as the Chief Scientific Officer (CSO) and Executive Vice President, Integrated Drug Discovery (IDD) and will be based in the USA. Jayadeva Sajankila has been ...
read more
Thursday, October 19, 2023
Aragen, a leading provider of contract research, development, and manufacturing services for the pharmaceutical, biotechnology, agrochemicals, and animal health sectors, has inaugurated its advanced formulations manufacturing facility in Hyderabad, ...
read more
Aragen Life Sciences announced an expansion of their discovery research agreement with Boehringer Ingelheim, with the goal of accelerating the discovery pipeline of Boehringer Ingelheim.
read more
Thursday, August 07, 2025
Aragen announced the appointment of Aniel Khubchandani as CEO of its Development & Manufacturing Solutions business. Aniel will be a member of Aragen’s Management Council and will be based in Hyderabad.
read more
Aragen, a Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, announced that it has operationalized the first phase of its biologics manufacturing facility in Bangalore, India through its 100% ...
read more
Aragen Life Sciences (formerly, GVK BIO), a leading Contract Research and Development Organization (CRDO), headquartered out of Hyderabad, India, announced that it has been selected by Skyhawk Therapeutics, a leader in the development of small ...
read more
Aragen, a Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, announced that it was setting up a new biologics manufacturing facility in Bangalore, India.
read more